- Home
- EIC vs AMRN Comparison
EIC vs AMRN Comparison
Compare EIC & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIC
- AMRN
- Stock Information
- Founded
- EIC N/A
- AMRN 1989
- Country
- EIC United States
- AMRN Ireland
- Employees
- EIC N/A
- AMRN N/A
- Industry
- EIC Finance/Investors Services
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- EIC Finance
- AMRN Health Care
- Exchange
- EIC Nasdaq
- AMRN Nasdaq
- Market Cap
- EIC 348.9M
- AMRN 317.1M
- IPO Year
- EIC 2019
- AMRN 1993
- Fundamental
- Price
- EIC $13.07
- AMRN $14.92
- Analyst Decision
- EIC
- AMRN Strong Sell
- Analyst Count
- EIC 0
- AMRN 1
- Target Price
- EIC N/A
- AMRN $12.00
- AVG Volume (30 Days)
- EIC 155.9K
- AMRN 50.2K
- Earning Date
- EIC 11-13-2025
- AMRN 10-29-2025
- Dividend Yield
- EIC 11.94%
- AMRN N/A
- EPS Growth
- EIC N/A
- AMRN N/A
- EPS
- EIC 0.70
- AMRN N/A
- Revenue
- EIC $55,581,156.00
- AMRN $219,361,000.00
- Revenue This Year
- EIC $37.84
- AMRN N/A
- Revenue Next Year
- EIC $23.33
- AMRN N/A
- P/E Ratio
- EIC $18.78
- AMRN N/A
- Revenue Growth
- EIC 56.39
- AMRN N/A
- 52 Week Low
- EIC $12.10
- AMRN $7.08
- 52 Week High
- EIC $16.71
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- EIC 40.60
- AMRN 46.35
- Support Level
- EIC $13.05
- AMRN $14.54
- Resistance Level
- EIC $13.45
- AMRN $15.46
- Average True Range (ATR)
- EIC 0.18
- AMRN 0.47
- MACD
- EIC -0.08
- AMRN -0.05
- Stochastic Oscillator
- EIC 2.30
- AMRN 31.93
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.